Bivalent boosters for kids, long COVID study, monkeypox decline & more with Andrea Garcia, JD, MPH

preview_player
Показать описание
AMA's Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares details of the FDA's authorization for COVID boosters for kids 5 to 11, early Pfizer data on the bivalent booster and a study on long COVID, plus the latest on monkeypox and Ebola. American Medical Association CXO Todd Unger hosts.

0:00 AMA Update for Oct. 17, 2022
0:27 FDA authorization of new bivalent COVID boosters for younger children 5 to 11.
1:40 Why is the COVID booster important?
2:18 New Pfizer data on the COVID booster
3:57 How are COVID cases trending?
4:23 How are COVID hospitalizations and deaths trending?
5:11 Long COVID study out of Scotland
6:25 Long COVID symptoms
7:17 How many people have long COVID in the U.S.?
7:56 Monkeypox trends
9:40 Ebola outbreak in Uganda
10:18 Vaccinations for Ebola

Рекомендации по теме